Paiva, Márcia <br/><br/>
FcgammaRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients.  [electronic resource] 

 -  Cancer genetics and cytogenetics  May 2008 
 - 35-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4456 
<br/><br/><label>Standard No.: </label>10.1016/j.cancergencyto.2008.02.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD--genetics<br/>Antineoplastic Agents--therapeutic use<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Frequency<br/>Humans<br/>Lymphoma, Non-Hodgkin--diagnosis<br/>Male<br/>Middle Aged<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Receptors, IgG--genetics<br/>Rituximab<br/>Survival Analysis<br/>Treatment Outcome